作者: Joseph M. Wiley , Nita L. Seibel , Thomas J. Walsh
DOI: 10.1097/01.INF.0000153183.51258.B8
关键词: Retrospective cohort study 、 Antibiotics 、 Antifungal 、 Aspergillosis 、 Mycosis 、 Amphotericin B-Lipid Complex 、 Organ transplantation 、 Amphotericin B 、 Intensive care medicine 、 Medicine 、 Internal medicine
摘要: Background:The safety and efficacy of amphotericin B lipid complex injection (ABELCET; Enzon Pharmaceuticals, Piscataway, NJ) was assessed in 548 children adolescents 0–20 years age who were enrolled the Collaborative Exchange Antifungal Research (CLEAR) registry. To our knowledge, this